U.S. – Japan Healthcare Connection

Connecting Japan with Silicon Valley innovation and entrepreneurship through its global network and broad healthcare programming capabilities.

Mission Statement

The U.S. – Japan Healthcare Connection strengthens the Silicon Valley/San Francisco Bay Area’s link with Japan through identifying and presenting the latest medical technology innovations and anticipated developments.

The U.S. – Japan Healthcare Connection is a collaboration between the Japan Society of Northern California (JSNC) and US-Japan Medtech Frontiers (USJMF), two leading Silicon Valley/San Francisco Bay Area organizations with deep and unique links to Japan. It is governed by the U.S. – Japan Healthcare Council.

U.S.-Japan Healthcare Connection Event in 2022

— The Future of Precision and Predictive Healthcare —

Japan Week 2022 | Meet American and Japanese Companies


Tokyo Executive Symposium
Oct 31, 2022
1:00–5:00 PM (JT)

Followed by Networking Reception

Awajishima Healthcare Forum
Nov 2nd, 2022
10:00 AM–6:00 PM (JT)

Followed by Networking Reception


Tokyo Executive Symposium:
Nihonbashi Life Science Hub Link

Awajishima Healthcare Forum:
Awaji Yumebutai International Conference Center Link

KEYNOTE (Tokyo & Awajishima Events)
Andrew Cleeland

Chief Executive Officer,
Fogarty Innovation


Andrew Cleeland is the CEO of Fogarty Innovationseasoned executive with more than 30 years of experience in the medical device industry, he has held key leadership positions in
organizations ranging from earlystage startups to large multinationals.


Past Event

The Future of Precision and Predictive Healthcare

Healthcare Symposium (May 24, 2022)

One important quest of healthcare is to prevent adverse events in individuals. The pandemic has been a worldwide tragedy, but it has brought a huge growth of telemedicine. Meanwhile, the proliferation of sensors and AI have increased availability of real time monitoring, and the development of correlations of an individual’s data to health outcomes. Combining all these factors and other data such as genetic sequencing and the Electronic Health Record (EHR) offer the opportunity to predict adverse events in patients. We will have Dean Lloyd Minor of the Stanford University School of Medicine as our keynote speaker and will also feature Japanese companies interested in products and technologies that might advance this concept and also interested in expanding their business and strategic partnerships in the US and globally.